Literature DB >> 25940640

Disutility in Patients with Hidradenitis Suppurativa: A Cross-sectional Study Using EuroQoL-5D.

Peter Theut Riis1, Gabrielle R Vinding, Hans Christian Ring, Gregor B E Jemec.   

Abstract

Disutility reflects the disability caused by a disease. The EuroQoL-5D (EQ-5D) questionnaire is a measure of health-related overall utility. The questionnaire has only been applied previously to a small number of patients with hidradenitis. In this study a survey of 421 patients with hidradenitis suppurativa was conducted using the EQ-5D questionnaire. Questions regarding pain, malodour and pruritus were included to determine quantitatively whether these factors are associated with low EQ-5D index and visual analogue scale (VAS) scores. The index and VAS scores obtained were compared with reference values for the general population in Denmark. A significantly decreased utility in patients with hidradenitis suppurativa was found for all age group levels, except for 65-74-year-olds. The total index score in the cohort was 0.705 (population mean 0.887) and the VAS was 62.25 (population mean 82.6). Multivariate analysis found significant associations between loss of utility and pain, malodour and pruritus (p < 0.0001). Patients with hidradenitis suppurativa had a significantly decreased EQ-5D compared with the background population. Malodour and pruritus were found to be associated with low index values, and pain and malodour with low VAS. Patient-reported pain and discomfort had the most negative overall effect on mean index scores.

Entities:  

Mesh:

Year:  2016        PMID: 25940640     DOI: 10.2340/00015555-2129

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  10 in total

1.  Qualitative study shows disease damage matters to patients with hidradenitis suppurativa.

Authors:  Joslyn S Kirby
Journal:  J Am Acad Dermatol       Date:  2016-06       Impact factor: 11.527

2.  Impact of a hidradenitis suppurativa patient decision aid on treatment decision making: A randomized controlled trial.

Authors:  Donna McLean; Olivia McBride; Tanja Samardzic; Mia Sisic; Robert P Dellavalle; Jerry Tan
Journal:  JAAD Int       Date:  2020-10-29

Review 3.  Itch in Hidradenitis Suppurativa/Acne Inversa: A Systematic Review.

Authors:  Puneet Agarwal; Snehal Balvant Lunge; Nandini Sundar Shetty; Priyanka Karagaiah; Steven Daveluy; Alex G Ortega-Loayza; Thrasyvoulos Tzellos; Jacek C Szepietowski; Christos C Zouboulis; Stephan Grabbe; Mohamad Goldust
Journal:  J Clin Med       Date:  2022-06-30       Impact factor: 4.964

Review 4.  Report from the International Dermatology Outcome Measures Initiative.

Authors:  Lourdes M Perez-Chada; Joseph F Merola; April W Armstrong; Amit Garg; John Latella; Alice B Gottlieb
Journal:  J Investig Dermatol Symp Proc       Date:  2020-11

5.  Development of HiSQOL: A Hidradenitis Suppurativa-Specific Quality of Life Instrument.

Authors:  Linnea Thorlacius; Solveig Esmann; Iben Miller; Gabrielle Vinding; Gregor B E Jemec
Journal:  Skin Appendage Disord       Date:  2019-02-14

6.  A core domain set for hidradenitis suppurativa trial outcomes: an international Delphi process.

Authors:  L Thorlacius; J R Ingram; B Villumsen; S Esmann; J S Kirby; A B Gottlieb; J F Merola; R Dellavalle; S M Nielsen; R Christensen; A Garg; G B E Jemec
Journal:  Br J Dermatol       Date:  2018-07-05       Impact factor: 11.113

7.  Assessing Pruritus in Hidradenitis Suppurativa: A Cross-Sectional Study.

Authors:  Allard R J V Vossen; Annelien Schoenmakers; Kelsey R van Straalen; Errol P Prens; Hessel H van der Zee
Journal:  Am J Clin Dermatol       Date:  2017-10       Impact factor: 7.403

Review 8.  An Update on Health-Related Quality of Life and Patient-Reported Outcomes in Hidradenitis Suppurativa.

Authors:  J Mac Mahon; S Kirthi; N Byrne; C O'Grady; A M Tobin
Journal:  Patient Relat Outcome Meas       Date:  2020-02-10

9.  The measurement performance of the EQ-5D-5L versus EQ-5D-3L in patients with hidradenitis suppurativa.

Authors:  Alex Bató; Valentin Brodszky; L Hunor Gergely; Krisztián Gáspár; Norbert Wikonkál; Ágnes Kinyó; Ákos Szabó; Zsuzsanna Beretzky; Andrea Szegedi; Éva Remenyik; Norbert Kiss; Miklós Sárdy; Fanni Rencz
Journal:  Qual Life Res       Date:  2021-02-03       Impact factor: 4.147

10.  Identifying Unmet Care Needs and Important Treatment Attributes in the Management of Hidradenitis Suppurativa: A Qualitative Interview Study.

Authors:  Damon Willems; Mickael Hiligsmann; Hessel H van der Zee; Christopher J Sayed; Silvia M A A Evers
Journal:  Patient       Date:  2021-08-09       Impact factor: 3.883

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.